Published in:
01-03-2021 | Uterine Sarcoma | ASO Author Reflections
ASO Author Reflections: Spotlight on Malignant Peritoneal Cytology in Uterine Sarcoma: A Potential Avenue for Future Research
Authors:
Shinya Matsuzaki, MD, PhD, Koji Matsuo, MD, PhD
Published in:
Annals of Surgical Oncology
|
Issue 3/2021
Login to get access
Excerpt
To date, only three studies < AQ1 > have investigated the effect of malignant peritoneal cytology (MPC) on the survival outcomes of uterine sarcoma.
1 Two of these studies (
n = 70) examined stages 1–4 uterine sarcomas and found that patients with MPC had a shorter survival than those with a negative peritoneal cytology.
2,
3 These limited studies highlight the fact that the effect of MPC on the survival outcome of uterine sarcoma has been understudied. …